Department of Paediatrics, University of Ghana Medical Centre, Legon, Accra, Ghana.
Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa.
Pediatr Nephrol. 2024 Feb;39(2):559-567. doi: 10.1007/s00467-023-06065-y. Epub 2023 Aug 3.
Acute kidney injury (AKI) is a frequent complication of children admitted to the paediatric intensive care unit. One key management modality of AKI is the use of diuretics to reduce fluid overload. Aminophylline, a drug that is well known for its use in the treatment of bronchial asthma, is also purported to have diuretic effects on the kidneys. This retrospective cohort study assesses the effect of aminophylline in critically ill children with AKI.
A retrospective chart review of children admitted to the paediatric intensive care unit of the Red Cross War Memorial Children's Hospital (RCWMCH) with AKI who received aminophylline (from 2012 to June 2018) was carried out. Data captured and analyzed included demographics, underlying disease conditions, medications, urine output, fluid balance, and kidney function.
Data from thirty-four children were analyzed. Urine output increased from a median of 0.4 mls/kg/hr [IQR: 0.1, 1.1] at six hours prior to aminophylline administration to 0.6 mls/kg/hr [IQR: 0.2, 1.9] at six hours and 1.6 mls/kg/hr [IQR:0.2, 4.2] at twenty-four hours post aminophylline therapy. The median urine output significantly varied across the age groups over the 24-h time period post-aminophylline, with the most response in the neonates. There was no significant change in serum creatinine levels six hours post-aminophylline administration [109(IQR: 77, 227)-125.5(IQR: 82, 200) micromole/l] P-value = 0.135. However, there were significant age-related changes in creatinine levels at six hours post-aminophylline therapy.
Aminophylline increases urine output in critically ill children with AKI. A higher resolution version of the Graphical abstract is available as Supplementary information.
急性肾损伤(AKI)是儿童入住儿科重症监护病房的常见并发症。AKI 的一种关键治疗方式是使用利尿剂来减少液体超负荷。氨茶碱是一种众所周知的用于治疗支气管哮喘的药物,据称也具有肾脏利尿作用。本回顾性队列研究评估了氨茶碱在患有 AKI 的危重症儿童中的作用。
对 2012 年至 2018 年 6 月期间在红十字会儿童纪念医院儿科重症监护病房(RCWMCH)接受氨茶碱治疗的 AKI 患儿进行回顾性图表审查。采集和分析的数据包括人口统计学、潜在疾病状况、药物、尿量、液体平衡和肾功能。
对 34 名儿童的数据进行了分析。在使用氨茶碱治疗前 6 小时,尿量中位数从 0.4 mls/kg/hr [IQR:0.1,1.1]增加到治疗后 6 小时的 0.6 mls/kg/hr [IQR:0.2,1.9]和 24 小时的 1.6 mls/kg/hr [IQR:0.2,4.2]。在使用氨茶碱治疗后 24 小时内,尿量中位数在不同年龄组之间有显著差异,新生儿的反应最大。在使用氨茶碱治疗后 6 小时,血清肌酐水平无显著变化[109(IQR:77,227)-125.5(IQR:82,200)微摩尔/升],P 值=0.135。然而,在使用氨茶碱治疗后 6 小时,肌酐水平与年龄有显著相关性变化。
氨茶碱可增加 AKI 危重症儿童的尿量。一个更高分辨率的图表摘要版本可以在补充材料中找到。